Corticosteroids - Topical: Nursing pharmacology
Definitions & Key takeaways
Topical corticosteroids are a group of medications used in the treatment of various skin conditions, such as psoriasis, eczematous rashes, lichen sclerosis, bullous pemphigoid, pemphigus foliaceous, and urticaria. They work by suppressing the inflammatory response, thus reducing inflammation and itching in the affected area.
Common topical corticosteroids include hydrocortisone, triamcinolone, and betamethasone clobetasol. Some side effects of topical corticosteroids include skin irritation, dryness, and redness. Long-term can also cause thinning of the skin, stretch marks, and increased risk of infections.
While caring for a client on a topical corticosteroid, nursing considerations include applying the medication to intact skin using a clean technique, as well as monitoring for side effects such as the development of infection or irritation at the application site. Client teaching is focused on how to apply the medication as directed and to report symptoms of systemic absorption or if the affected area does not respond to treatment.
Introduction0:00–0:35
Topical corticosteroids0:35–1:01
Mechanism of action1:01–1:40
Side effects1:40–2:40
Contraindications and cautions2:40–2:53
Nursing considerations & client education2:53–4:35
Review4:35–5:26
| TOPICAL CORTICOSTEROIDS | |||
| DRUG NAME | hydrocortisone 0.5–2.5% (Ala-Cort, Ala-Scalp, Anusol HC Cetacort, Procort, Cortizone-5, Cortizone-10, Procort, Texacort) | triamcinolone 0.025–0.1% (Kenalog, Triderm); betamethasone 0.1% (Beta-Val, Dermabet, Luxiq, Valnac) | betamethasone 0.05% (Diprolene, Diprolene AF, Sernivo); clobetasol 0.05% (Clobex, Cormax, Olux, Olux-E, Temovate, Temovate-E) |
| CLASS | Low potency topical corticosteroids | Intermediate potency topical corticosteroids | High potency topical corticosteroids |
| MECHANISM OF ACTION |
| ||
| INDICATIONS |
| ||
| ROUTE(S) OF ADMINISTRATION |
| ||
| SIDE EFFECTS |
| ||
| CONTRAINDICATIONS AND CAUTIONS |
| ||
| NURSING CONSIDERATIONS: TOPICAL CORTICOSTEROIDS | |||
| ASSESSMENT AND MONITORING | All topical corticosteroids Assess
Administration
Monitor
| ||
| CLIENT EDUCATION | All topical corticosteroids
| ||
- "Karch’s Focus on Nursing Pharmacology. 9th edition. ISBN: 978-1-975180-40-9" LWW (2023)
- "Pharmacology: A Patient-Centered Nursing Process Approach. 9th edition. ISBN: 978-0-323-39916-6 " Elsevier Canada (2020)
- "Mosby’s 2023 Nursing Drug Reference. 36th edition. ISBN: 978-0-323-93072-7" Mosby (2022)
- "Saunders Comprehensive Review for the NCLEX-RN. 9th Edition. ISBN: 978-0-323-79530-2" Saunders (2022)
- "Immune checkpoint inhibitor-related dermatologic adverse events. 83(5):1255-1268" J Am Acad Dermatol (2020)
- "Strategies for using topical corticosteroids in children and adults with eczema. 3(3):CD013356" Cochrane Database Syst Rev (2022 Mar 11)
- "Psoriasis: a brief overview. 21(3):170-173" Clin Med (Lond) (2021)
No notes for this video yet
Try adding a note below